Azithromycin is no longer a standard part of gonorrhea treatment. It was once paired with an injection of ceftriaxone as dual therapy, but the CDC dropped that combination in 2020. Today, azithromycin is only used for gonorrhea in specific situations, primarily when a patient has a cephalosporin allergy and needs an alternative regimen.
Why Azithromycin Was Removed From Standard Treatment
For years, the recommended approach to gonorrhea was a two-drug combination: an injection of ceftriaxone plus a dose of oral azithromycin. The idea was that two antibiotics working through different mechanisms would reduce the chance of the bacteria developing resistance to either one.
In December 2020, the CDC changed course. The updated guideline recommends treating uncomplicated gonorrhea with a single, higher-dose injection of ceftriaxone alone. Three factors drove the change: growing concern about antibiotic stewardship (using antibiotics only when truly needed), continued low rates of ceftriaxone resistance, and a troubling shift in how well azithromycin was working against gonorrhea bacteria.
Rising Resistance Is the Core Problem
Gonorrhea bacteria have been steadily losing their sensitivity to azithromycin. A global systematic review found that resistance rates climbed from about 2.3% of tested samples in the period from 1988 to 2013, up to roughly 7.3% from 2019 to 2021. That may sound small, but for a sexually transmitted infection that affects millions of people each year, even single-digit resistance means a large number of treatment failures.
Azithromycin works by binding to a part of the bacteria’s protein-building machinery, preventing the bacteria from assembling the proteins they need to survive and multiply. But gonorrhea is notoriously adaptable. As more strains develop the ability to shrug off azithromycin, using it routinely accelerates the problem. Pulling it from the standard regimen helps preserve its usefulness for situations where it’s genuinely needed.
When Azithromycin Is Still Used
If you have a confirmed allergy to cephalosporins (the drug class that includes ceftriaxone), azithromycin remains part of the backup plan. The alternative regimen pairs a single injection of gentamicin with a single high oral dose of azithromycin (2 grams, which is significantly more than the typical azithromycin prescription). In a clinical trial, this combination cured 100% of gonorrhea cases, with a lower confidence bound of 98.5%.
This combination is also an option if you have a suspected severe penicillin allergy, since cephalosporins and penicillins are chemically related and cross-reactivity is possible. Your provider would use this gentamicin-plus-azithromycin approach as a substitute.
Why Azithromycin Alone Won’t Work
Taking azithromycin by itself to treat gonorrhea is not recommended. Even at the high 2-gram dose, using it as a solo treatment carries a real risk of failure given current resistance patterns. The bacteria that survive an incomplete treatment become harder to kill, both for you and for anyone you might pass the infection to. Gonorrhea requires a treatment strategy built around ceftriaxone or, when that’s not an option, a carefully chosen two-drug alternative.
If you were prescribed azithromycin for chlamydia and are wondering whether it also covered a gonorrhea infection, the answer is no. The standard chlamydia dose of azithromycin (1 gram) is not effective against gonorrhea, and even the higher 2-gram dose is not used on its own.
What Current Treatment Looks Like
For most people, gonorrhea treatment is a single visit. The standard approach is one injection of ceftriaxone, typically given in the arm or buttock. There are no pills to take at home and no multi-day course to complete. The infection usually clears within a few days.
If you receive the alternative regimen with azithromycin, expect the injection of gentamicin plus the oral azithromycin at the same visit. Be aware that the 2-gram dose of azithromycin is four times the typical dose and commonly causes gastrointestinal side effects, including nausea, vomiting, and diarrhea. Taking it on a full stomach can help.
Follow-Up After Treatment
For gonorrhea infections of the genitals or rectum, a follow-up test to confirm the infection has cleared is generally unnecessary when you receive the recommended or alternative regimens. The cure rates are high enough that routine retesting adds little value.
Throat infections are the exception. Gonorrhea in the pharynx is harder to treat regardless of which regimen is used, so the CDC recommends a test of cure 7 to 14 days after treatment. This can be done with a throat swab sent for culture or a nucleic acid test. If you were treated for pharyngeal gonorrhea with the azithromycin-containing alternative, this follow-up step is especially important.
Retesting for a new infection (as opposed to confirming the original one cleared) is recommended about three months after treatment, since reinfection rates are high.